Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-03 Purchase |
2022-05-05 5:23 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
525,000 | $1.9358 | $1,016,285 | 6,841,423 (Indirect) |
View |
| 2022-01-20 Purchase(A) |
2022-05-05 5:11 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
50,800 | $5 | $254,000 | 6,316,423 (Indirect) |
View |
| 2022-04-06 Sale |
2022-04-08 6:06 pm |
Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner |
878,200 | $20.68 | $18,163,608 | 451,086 (Indirect) |
View |
| 2022-02-11 Purchase |
2022-02-15 9:42 pm |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director |
195,700 | $10.17 | $1,989,446 | 4,043,629 (Indirect) |
View |
| 2022-01-20 Purchase |
2022-01-24 4:44 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
369,100 | $5.42 | $2,000,522 | 6,634,723 (Indirect) |
View |
| 2022-01-19 Purchase |
2022-01-21 7:18 pm |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
158,417 | $9.9656 | $1,578,717 | 17,041,802 (Indirect) |
View |
| 2022-01-14 Purchase |
2022-01-20 6:03 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
168,300 | $5.3785 | $905,205 | 6,265,623 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 7:37 pm |
Passage BIO Inc. | PASG | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
150,000 | $5.6072 | $841,082 | 6,097,323 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 7:18 pm |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
44,717 | $9.9012 | $442,750 | 16,883,385 (Indirect) |
View |
| 2021-12-16 Sale |
2021-12-17 5:13 pm |
Janux Therapeutics Inc. | JANX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director |
393,300 | $19.07 | $7,500,231 | 245,898 (Indirect) |
View |
| 2021-10-12 Purchase |
2021-10-14 5:00 pm |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
625,000 | $16 | $10,000,000 | 499,150 (Indirect) |
View |
| 2021-09-03 Sale |
2021-09-08 6:18 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
8,084 | $33.99 | $274,794 | 96,190 (Indirect) |
View |
| 2021-08-31 Sale |
2021-09-02 8:27 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
37,864 | $34.08 | $1,290,550 | 96,428 (Indirect) |
View |
| 2021-08-26 Sale |
2021-08-30 6:37 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
18,073 | $34.07 | $615,748 | 97,542 (Indirect) |
View |
| 2021-08-23 Sale |
2021-08-25 8:43 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
18,215 | $34.17 | $622,426 | 98,074 (Indirect) |
View |
| 2021-08-17 Sale |
2021-08-19 8:55 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
20,328 | $34.1 | $693,210 | 98,610 (Indirect) |
View |
| 2021-07-16 Purchase(A) |
2021-07-23 5:30 pm |
IMARA Inc. | IMRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner |
1,666,666 | $6 | $9,999,996 | 4,199,068 (Indirect) |
View |
| 2021-07-16 Purchase |
2021-07-16 4:27 pm |
IMARA Inc. | IMRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director 10% Owner |
1,666,666 | $6 | $9,999,996 | 4,199,068 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:09 pm |
Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner |
475,000 | $17 | $8,075,000 | 2,274,723 (Indirect) |
View |
| 2020-12-02 Purchase |
2020-12-04 6:11 pm |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director 10% Owner |
750,000 | $20 | $15,000,000 | 450,000 (Indirect) |
View |
| 2020-11-02 Purchase |
2020-11-04 8:00 pm |
Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
733,333 | $15 | $10,999,995 | 1,313,329 (Indirect) |
View |
| 2020-10-02 Purchase |
2020-10-06 5:27 pm |
Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC Director 10% Owner |
496,000 | $25 | $12,400,000 | 902,286 (Indirect) |
View |
| 2020-06-30 Purchase |
2020-07-02 4:02 pm |
Fusion Pharmaceuticals Inc. | FUSN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
898,000 | $17 | $15,266,000 | 192,100 (Indirect) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:53 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
774,200 | $20 | $15,484,000 | 99,200 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-26 Exercise |
2022-01-28 9:22 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner |
431,206 | $13.2 | 226,704 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 9:22 pm |
2020-01-22 N/A |
Sierra Oncology Inc. | SRRA | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner |
487,450 | $0 | 226,704 (Indirect) |
View |
| 2021-10-12 Conversion |
2021-10-14 5:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
31,990,686 | $0 | 499,150 (Indirect) |
View |
Ownership |
2021-10-06 7:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
0 | $0 | 16,213,668 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 3:09 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner |
6,632,408 | $0 | 2,274,723 (Indirect) |
View |
Ownership |
2021-02-04 5:07 pm |
N/A N/A |
Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd Director 10% Owner |
0 | $0 | 3,316,204 (Indirect) |
View |
| 2020-12-07 Conversion |
2020-12-09 4:24 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC ORBIMED CAPITAL LLC Director 10% Owner |
3,240,882 | $0 | 534,599 (Indirect) |
View |
Ownership |
2020-12-02 9:07 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
0 | $0 | 3,097,929 (Indirect) |
View |
| 2020-09-25 Option Award |
2020-11-04 8:00 pm |
N/A N/A |
Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
281,518 | $27.11 | 1,313,329 (Indirect) |
View |
| 2020-11-02 Conversion |
2020-11-04 8:00 pm |
N/A N/A |
Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
4,250,798 | $0 | 1,313,329 (Indirect) |
View |
Ownership |
2020-10-28 9:12 pm |
N/A N/A |
Galecto Inc. | GLTO | ORBIMED ADVISORS LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
0 | $0 | 3,069,922 (Indirect) |
View |
Ownership |
2020-07-16 8:40 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC 10% Owner |
0 | $0 | 657,492 (Indirect) |
View |
| 2020-06-30 Conversion |
2020-07-02 4:02 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
14,102,821 | $0 | 192,100 (Indirect) |
View |
Ownership |
2020-06-25 8:01 pm |
N/A N/A |
Fusion Pharmaceuticals Inc. | FUSN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director |
0 | $0 | 2,292,081 (Indirect) |
View |
| 2020-06-23 Conversion |
2020-06-25 5:53 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
2,601,325 | $0 | 99,200 (Indirect) |
View |
Ownership |
2020-06-18 9:34 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner |
0 | $0 | 2,601,325 (Indirect) |
View |